Anita Burrell | VP, Teriflunomide/MS Unit Head
Sanofi

Anita Burrell, VP, Teriflunomide/MS Unit Head, Sanofi

Share this

Appearances at this years' conference:

Conference Day Two: Thursday 18th October 2012


@ 09.30
Risk sharing US vs European perspectives

  • › Anita Burrell, VP, Teriflunomide/MS Unit Head, Sanofi
Sponsors
Presentation sponsors
GfK Bridgehead at Market Access World USA 2012
Sponsor
GalbraithWight at Market Access World USA 2012